Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

15 Sep 2023
0

Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

Rawangkan A, Wongsirisin P, Pook-In G, Siriphap A, Yosboonruang A, Kiddee A, Chuerduangphui J, Reukngam N, Duangjai A, Saokaew S, Praphasawat R

Antibiotics. 2022;11(12):1845.

Tags

Share this

Related Posts

Over-Expression of Hypochlorite Inducible Major Facilitator Superfamily (MFS) Pumps Reduces Antimicrobial Drug Susceptibility by Increasing the Production of MexXY Mediated by ArmZ in Pseudomonas aeruginosa. Dulyayangkul P, Satapoomin N, Avison MB, Charoenlap N, Vattanaviboon P, Mongkolsuk S. Front Microbiol. 2021 Jan 12;11:592153. doi: 10.3389/fmicb.2020.592153. eCollection 2020. PMID: 33510718

Recent Posts